Despite having higher rates of pathologic complete response (pCR) than ER, PR, and HER-2 positive tumors, patients with TNBC still have lower rates of progression free and overall survival.4 The treatment of breast cancer involves a multidisciplinary approach consisting of chemotherapy, radiation, and surgical resection. This evidence concerns the gene ERBB2 and breast carcinoma.